ArticleResearch and practice in thrombosis and haemostasis2026
Pregnancy outcomes in women with Von Willebrand disease: a statewide cohort study.
Article in Research and practice in thrombosis and haemostasis, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Multiple studies conducted between 1990s and 2010s reported increased rates of postpartum hemorrhage (PPH) among women with von Willebrand disease (VWD), even with specialized peripartum care. Objective: To generate contemporary data on pregnancy outcomes among women with VWD using a statewide database, the Utah Population Database. Methods: We included women with a first live singleton birth at Intermountain Health or University of Utah facilities from January 1, 2008, to December 31, 2020. VWD cases were identified using a validated algorithm incorporating diagnosis codes, laboratory, and medication data. Each case was matched (∼1:20) to controls by maternal birth year and age at delivery. Pregnancy outcomes were obtained from Utah birth certificates; PPH became reportable in 2017. Mixed effects logistic regression was used to compare pregnancy outcomes between women with and without VWD for the full cohort (2008-2020) and a limited cohort (2017-2020). Results: We identified 120 women with VWD matched to 2356 controls for the full cohort. Compared with controls, women with VWD had higher odds of blood transfusion (adjusted odds ratio [aOR] 12.8, 95% CI, 4.11-40.1) and preterm birth (aOR 1.82; 95% CI, 1.04-3.20), after adjusting for ethnicity. In the limited cohort, VWD was not significantly associated with PPH (aOR 1.59, 95% CI, 0.36-6.95). Conclusion: Despite increased awareness, women with VWD continue to face a higher risk of adverse pregnancy outcomes compared to the general population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.